Nifty  22475.85  -172.35  (-0.76%)

Sensex  73878.15  -732.96  (-0.98%)

USDINR  83.49  0.00  (0.00%)

Remus Pharmaceuticals Ltd
Registered Office:
1101 to 1103 South Tower One42,B/H Ashok Vatika Amblibopal Rd, Ahmedabad - 380054, Gujarat, India.
Initial public issue of 388000 equity shares of face value of Rs. 10/- each of Remus Pharmaceuticals Limited ("RPL" or the "Company" or the "Issuer") for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share (the "Issue Price") aggregating to Rs. 47.69 crores ("The Issue"), of which 19500 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 2.40 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 368500 equity shares of face value of Rs. 10/- each at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share aggregating to Rs. 45.29 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.34% and 25.02%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each.
Issue
Opens On Closes On
17-May-23 19-May-23
Money Payable On
Application Allotment
1229.00 0.00
Minimum Application for shares in Nos : 100  Further Multiples of : 100
()(Cr.) Lead Managers to the Issue
Project Cost () 46.69 Beeline Capital Advisors Pvt Ltd
Project Financed through Current Offer () 47.69  
Post Issue Equity Share Capital () 1.47  
Issue Price () 1229.00  
Projects
To Meet Working Capital Requirements
Funding investments for acquisitions & general corporate purposes
Promoted By
Arpit Deepakkumar Shah
Roma Vinodbhai Shah
Swapnil Jatinbhai Shah
Listing At
NSE - SME
Registrar to the Issue